Retatrutide appears to be a new medication in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By activating these https://katrinamvii359107.blogocial.com/tirzepatide-a-promising-new-treatment-for-obesity-71881221